Evidence map›Paper›PMID 32913445›Full record

ArticleTherapeutic advances in neurological disorders2020

Vision improvement in severe acute isolated optic neuritis after plasma exchange treatment in Chinese population: a prospective case series study.

Shaoying Tan, Tsz Kin Ng, Quangang Xu, Mo Yang, Yuan Zhuang, Jie Zhao, Huanfen Zhou, Da Teng, Shihui Wei

Open access · goldAbstract read
In one paragraph

Article in Therapeutic advances in neurological disorders, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Update on glial antibody-mediated optic neuritis.Japanese journal of ophthalmology · 2022
    Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Shaoying TanJoint Shantou International Eye Centre of Shantou University and The Chinese University of Hong Kong, Shantou, Guangdong, China.
Tsz Kin NgJoint Shantou International Eye Centre of Shantou University and The Chinese University of Hong Kong, North Dongxia Road, Shantou, Guangdong 515041, China.ORCID https://orcid.org/0000-0001-7863-7229
Quangang XuDepartment of Ophthalmology, The Chinese People's Liberation Army General Hospital, Beijing, China.
Mo YangDepartment of Ophthalmology, The Chinese People's Liberation Army General Hospital, Beijing, China.
Yuan ZhuangDepartment of Haematology, The Chinese People's Liberation Army General Hospital, Beijing, China.
Jie ZhaoDepartment of Ophthalmology, The Chinese People's Liberation Army General Hospital, Beijing, China.
Huanfen ZhouDepartment of Ophthalmology, The Chinese People's Liberation Army General Hospital, Beijing, China.
Da TengDepartment of Ophthalmology, The Chinese People's Liberation Army General Hospital, Beijing, China.
Shihui WeiDepartment of Ophthalmology, The Chinese People's Liberation Army General Hospital, Beijing, 100853, China.
People's Liberation Army No. 150 Hospital · CNChinese University of Hong Kong · HK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPlasma exchange (PE) is often considered as an effective treatment for neuromyelitis optica spectrum disorder (NMOSD) and several inflammatory demyelinating disorders of the central nervous system. This study aimed to evaluate the visual outcomes of Chinese patients with severe acute isolated optic neuritis (ON) who received PE therapy after high-dose intravenous methylprednisolone (IVMP) treatment.

methodsThirty-seven acute isolated ON patients experiencing their first attack of severe visual impairment without neurological disability were recruited. All subjects received five cycles of double-filtration plasmapheresis. Visual acuity (VA) was documented at onset, 1 day before PE treatment, at each cycle of PE therapy and at the 1-month follow-up visit.

resultsThis study included 26 female (70.3%) and 11 male (29.7%) subjects, and 18 subjects (48.6%) had bilateral involvement. The time window between onset and PE treatment was 27.3 ± 12.7 days (range: 6-53 days). Mean VA (logMAR) of the studied eyes at onset, 1-day before PE treatment/after IVMP and after the fifth PE treatment were 3.41 ± 1.50, 2.61 ± 1.64 and 1.66 ± 1.52, respectively (

conclusionThis study revealed that PE treatment effectively improves the visual outcomes of patients experiencing their first attack of severe acute isolated ON after high-dose IVMP treatment. Better visual outcomes can be achieved with early PE treatment.

Indexed as

acute severe optic neuritisplasma exchangevision improvementvisual acuity

Identifiers

PMID32913445
PMCPMC7445352
OpenAlexW3081424702

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.